OSTEOARTHRITIS
Leukocyte-poor PRP may improve outcomes following arthroscopy for knee osteoarthritis
This report has been verified
by one or more authors of the
original publication.
Arch Orthop Trauma Surg. 2015 Jul;135(7):971-7.
Fifty eight patients with osteoarthritis (OA) were randomized to receive arthroscopic treatment with or without intra-operative leukocyte-poor platelet-rich plasma (LP-PRP) injection. The goal of this study was to determine if there were any benefits to the added PRP intervention in terms of pain, function, or quality of life. The primary outcome of interest was pain as measured at 6 months after surgery. Results demonstrated lower pain at 6 months for patients receiving LP-PRP, as well as significantly higher scores on function and quality-of-life measures up to one year after surgery, as compared to patients who underwent arthroscopy alone.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
